Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab

Overview of attention for article published in Targeted Oncology, February 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 14 X posts from 12 X users, with an upper bound of 10,635 followers.

RT @TargetOncology: Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine…

RT @TargetOncology: Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine…

Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab https://t.co/o2RV1rODIj #immunotherapy #BTC https://t.co/LTzN6g7ZzX

RT @casadei_gardini: CisGem durvalumab cholangiocarcinoma Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.